GenerexBiotechnology

An integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies.

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s https://t.co/3EvbzD8gnd

[GenerexBiotechnology @GenerexBiotech]

NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm https://t.co/fa3DFw8jd3

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services https://t.co/9ExQedDmS4

[GenerexBiotechnology @GenerexBiotech]

Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets https://t.co/jdmgUHpzii

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services https://t.co/hb1PR1q6MD

[GenerexBiotechnology @GenerexBiotech]

Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement https://t.co/FNbu0ND5Gs

[GenerexBiotechnology @GenerexBiotech]

https://t.co/8OZFTHUbZa

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Thursday May 6, 2021 at 9:00 AM https://t.co/XlabKOX0O6

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia https://t.co/O57bJiOC0M

[GenerexBiotechnology @GenerexBiotech]

The Big Biz Show - April 13, 2021 - Joseph Moscato https://t.co/YfNZoxy0LT via @YouTube

[GenerexBiotechnology @GenerexBiotech]

Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development https://t.co/2UkB1bK0uF

[GenerexBiotechnology @GenerexBiotech]

NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission https://t.co/Z3eb3dleRV

[GenerexBiotechnology @GenerexBiotech]

Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women https://t.co/uyRUPLzKF2

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Announces Shareholder Conference Call Scheduled for Thursday May 6, 2021 https://t.co/9juqXn8b9z

[GenerexBiotechnology @GenerexBiotech]

Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program https://t.co/gu05Pn3MjB

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM https://t.co/ddC7BLfJIr

[GenerexBiotechnology @GenerexBiotech]

A recent large multinational study found that loss of sense of smell and taste was the symptom most suitable to predict #COVID19 infection.

https://t.co/5ce3oROkBi

[GenerexBiotechnology @GenerexBiotech]

According to the #CDC, a good night's sleep is important for managing #diabetes, with a lack of sleep promoting diabetes in multiple ways.

https://t.co/5Rm7ZuEYNy

[GenerexBiotechnology @GenerexBiotech]

Generex Biotechnology Announces Investor Conference Call Scheduled for Friday February 5, 2021 at 9:00 AM https://t.co/jGhojZvwei

[CDC @CDCgov]

If you have recovered from #COVID19, still #WearAMask. Cases of reinfection have been reported but remain rare. Reinfection means a person got sick, recovered, and then got sick again. Learn more: https://t.co/iOQv5OMdKA.